advertisement
14 Costing studies; pharmacoeconomics (7)
Showing records 1 to 7
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics24227 The impact of a glaucoma nurse specialist role on glaucoma waiting lists
Slight C; Marsden J; Raynel S
Nursing praxis in New Zealand inc 2009; 25: 38-47
24299 Creating patient value in glaucoma care: applying quality costing and care delivery value chain approaches--a five-year case study in the Rotterdam Eye Hospital
de Korne DF; Sol K; Custers T; van Sprundel E; van Ineveld BM; Lemij HG; Klazinga NS
International journal of health care quality assurance 2009; 22: 232-251
24377 A critical review of the full economic evaluations of pharmacological treatments for glaucoma
Koleva D; De Compadri P; Virgili G; Nobili A; Garattini L
Journal of Medical Economics 2008; 11: 719-741
24376 Modelling the lifetime economic consequences of glaucoma in France
Nordmann JP; Lafuma A; Berdeaux G
Journal of Medical Economics 2009; 12: 9-16
24027 Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006
Schmier JK; Covert DW; Lau EC; Robin AL
Archives of Ophthalmology 2009; 127: 900-905
24256 First-year treatment patterns among new initiators of topical prostaglandin analogs
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2009; 25: 851-858
24447 Cost-effectiveness of latanoprost, travoprost and bimatoprost for the treatment of glaucoma in Norway, Sweden and Denmark, using a decision-analytic health economic model
Stewart WC; Stewart JA; Mychaskiw MA
International Journal of Ophthalmology 2009; 9: 812-816
